Annals of Vascular Surgery

, Volume 9, Issue 1, pp 80–86 | Cite as

Preventing intimal hyperplasia with photodynamic therapy using an intravascular probe

  • York Hsiang
  • Gordon Houston
  • Teresa Crespo
  • Eleanor To
  • Mary Todd
  • Mohammed Sobeh
  • Robert Bower
Papers from the Peripheral Vascular Surgery Society


The purpose of this study was to determine the efficacy of intravascular photodynamic therapy (PDT) to prevent the development of intimal hyperplasia. Anesthetized New Zealand white rabbits underwent placement of Fogarty balloon catheters introduced via femoral artery cutdowns. Catheters were passed retrograde 10 cm into the lower abdominal aorta, inflated six times, and withdrawn toward the inguinal ligament. Rabbits were then randomly assigned to one of the following groups: group 1, drug with no light; group 2, no drug with 240 joules of light; group 3, drug plus 120 joules of light; or group 4, drug plus 240 joules of light. Uninjured carotid arteries served as negative control vessels (N) and injured but non-PDT-treated iliac artery segments served as positive controls (P). Porfimer sodium (Photofrin) was administered in a dose of 5.0 mg/kg. Light was provided by a fiberoptic probe with a 1 cm cylindric diffuser attached to an argon pumped dye laser tuned to 630 nm to provide 1 W of laser light for 120 or 240 seconds. One month after PDT, rabbits were killed, perfusion fixed with glutaraldehyde, and vessels removed and examined microscopically. Intimal thickness (mean ± SD) was calculated and expressed as ratios of the intima/media at four equal positions. Results for N, P, and groups 1, 2, 3, and 4 were 0.02±0.00, 1.18±0.71, 0.76±0.33, 0.96±0.43, 0.14±0.22, and 0.36±0.16, respectively. Intimal thickness was significantly reduced in groups 3 and 4 when compared with P, group 1, and group 2 (p<0.001, ANOVA). These results showed that intravascular PDT was effective in reducing intimal hyperplasia following arterial injury. This may be a practical method of delivering light for PDT.


Photodynamic Therapy Zealand White Rabbit Intimal Hyperplasia Artery Segment Arterial Injury 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Clowes AW, Reidy MA. Prevention of stenosis after vascular reconstruction: Pharmacologic control of intimal hyperplasia-a review. J Vasc Surg 1991;13:885–891.PubMedGoogle Scholar
  2. 2.
    Lindner V, Lappi DA, Baird A, et al. Role of basic fibroblast growth factor in vascular lesion formation. Circ Res 1991;68: 106–113.PubMedGoogle Scholar
  3. 3.
    Painter TA. Myointimal hyperplasia: Pathogenesis and implications. 2. Animal injury models and mechanical factors. Artif Organs 1991;15:103–118.PubMedGoogle Scholar
  4. 4.
    Clowes AW, Karnovsky MJ. Suppression by heparin of smooth muscle cell proliferation in injured arteries. Nature 1977;265:625–626.PubMedGoogle Scholar
  5. 5.
    Powell JS, Clozel JP, Muller RKM, et al. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science 1989;245:186–188.PubMedGoogle Scholar
  6. 6.
    Manyak MJ, Russo A, Smith PD, et al. Photodynamic therapy. J Clin Oncol 1988;6:380–391.PubMedGoogle Scholar
  7. 7.
    Spears JR. Photosensitization. In Isner J, Clarke R, eds. Cardiovascular Laser Therapy. New York: Raven Press, 1989, pp 107–120.Google Scholar
  8. 8.
    Girotti AW. Photodynamic lipid peroxidation in biological systems. Photochem Photobiol 1990;51:497–509.PubMedGoogle Scholar
  9. 9.
    Dartsch PC, Ischinger T, Betz E. Responses of cultured smooth muscle cells from human atherosclerotic arteries and primary stenosing lesions after photoradiation: Implications for photodynamic therapy of vascular stenoses. J Am Coll Cardiol 1990;15:1545–1550.PubMedGoogle Scholar
  10. 10.
    Ortu P, LaMuraglia GM, Roberts G, et al. Photodynamic therapy of arteries. A novel approach for treatment of experimental intimal hyperplasia. Circulation 1992;85:1189–1196.PubMedGoogle Scholar
  11. 11.
    Eton D, Colburn MD, Shim V, et al. Inhibition of intimal hyperplasia by photodynamic therapy using photofrin. J Surg Res 1992;53:558–562.PubMedGoogle Scholar
  12. 12.
    Hsiang YN, Crespo MT, Todd ME. Dosage and timing of Photofrin for photodynamic therapy of intimal hyperplasia. Cardiovasc Surg (in press).Google Scholar
  13. 13.
    Spears JR, Serur J, Shropshire D, et al. Fluorescence of experimental atheromatous plaques with hematoporphyrin derivative. J Clin Invest 1983;71:395–397.PubMedGoogle Scholar
  14. 14.
    Spokojny AM, Serur JR, Skillman J, et al. Uptake of hematoporphyrin derivative by atheromatous plaques: Studies on human in vitro and rabbit in vivo. J Am Clin Cardiol 1986; 8:1387–1392.Google Scholar
  15. 15.
    Neave V, Giannotta S, Hyman S, et al. Hematoporphyrin uptake in atherosclerotic plaques: Therapeutic potentials. Neurosurg 1988;23:307–312.Google Scholar
  16. 16.
    Vincent GM, Mackie RW, Orme E, et al. In vivo photosensitizer-enhanced laser angioplasty in atherosclerotic Yucatan miniswine. J Clin Laser Med Surg 1990;9:59–61.Google Scholar
  17. 17.
    Hsiang YN, Crespo MX, Todd ME, et al. Treatment of atherosclerosis with photodynamic therapy in Yucatan miniswine. Can J Surg 1994;37:148–152.PubMedGoogle Scholar
  18. 18.
    Sumpio BE, Phan SM, Gasparro FP, et al. Control of smooth muscle cell proliferation by psoralen photochemotherapy. J Vasc Surg 1993;17:1010–1018.PubMedGoogle Scholar
  19. 19.
    March KL, Patton BL, Wilensky RL, et al. 8-Methoxypsoralen and long wave ultraviolet irradiation are a novel antiproliferative combination for vascular smooth muscle. Circulation 1993;87:184–191.PubMedGoogle Scholar
  20. 20.
    LaMuraglia GM, Chandra Sekar NR, Flotte TJ, et al. Photodynamic therapy inhibition of experimental intimal hyperplasia: Acute and chronic effects. J Vasc Surg 1994;19:321–331.PubMedGoogle Scholar
  21. 21.
    Vincent GM, Fox J, Charlton G, et al. Presence of blood significantly decreases transmission of 630 nm laser light. Laser Surg Med 1991;11:399–403.Google Scholar
  22. 22.
    Asahara T, Usui M, Amemiya T, et al. The photodynamic therapy for the prevention of restenosis after angioplasty. Proc Soc Photo-optical Instrumentation Engineers 1993, 1878:119–124.Google Scholar
  23. 23.
    Vincent GM, Fox J, Hill S. Benzophorphyrin derivative markedly inhibits smooth muscle/intimal proliferation in a restenosis model [abst]. Circulation 1993;88(Suppl):I-657.Google Scholar

Copyright information

© Annals of Vascular Surgery Inc. 1995

Authors and Affiliations

  • York Hsiang
    • 1
  • Gordon Houston
  • Teresa Crespo
  • Eleanor To
  • Mary Todd
    • 1
  • Mohammed Sobeh
  • Robert Bower
  1. 1.Departments of Surgery and AnatomyUniversity of British ColumbiaVancouverCanada

Personalised recommendations